The capital infusion continues to work its magic--- bull run from yahoo news wire by yours truly....
rally started last week, continued this week with the major indexes surging upward toward their 50-day simple moving averages.
ADVERTISEMENT plus EDIT EDIT EDIT EDIT
Monday saw a stock buying frenzy led by the battered down financial sector on the heels of the government backed plan to rescue Citigroup. The rally continued on Tuesday with word of an $800 billion dollar Federal cash infusion to thaw the frozen consumer credit markets. However, the Nasdaq did not participate due to weakness in technology names.
The nomination of Paul Volcker to head the Economic Recovery Advisory Board was greeted with great optimism on Wednesday with the indexes pushing even higher. The Thanksgiving holiday fell on Thursday and the stock market was closed. Friday is an abbreviated session with the market closing early on the day. Stocks are currently trading mixed with the DJIA higher and the Nasdaq and S&P 500 slightly lower in the first 30 minutes of trade.
The government cash infusion, bargain hunters, and a tremendous amount of cash just waiting to be deployed should continue to lift stocks. However, no one really knows what's going to happen in the future, we can just analysis the evidence and make the best educated decisions. With this is mind, proven tools are critical in times like these to assist you in making the optimal investing decisions.
\edit edit edit////.,.,.,sdfdfdleditofromthesitethatidarenotspeakitsnameuyahahooyah00testqwerereewtestwereryahoowererethesitethatidarenotspeakitsnameediteditedityahooeditedityahoo
ConAgra Foods (NYSE:CAG - News) - This packaged food company who reaches consumers via grocery stores and restaurants was upgraded from a 6 to a 7 Long Term PowerRating on Monday. Hunts canned tomatoes, Orville Redenbacher's popcorn, and Chef Boyardee are the some of the company's popular brands. They just reported strong fiscal first quarter results with sales up 17% and a projection of Earnings Per Share to be above $1.50 for Fiscal 2009. Technically, the stock has been downtrending; however it appears to have bottomed around $14.00/share. Price is currently bouncing up off of the $14.00 area but still solidly below the 50 and 200-day simple moving averages.
Amphenol (NYSE:APH - News) - An electronic system and coaxial cable manufacturer with a name that sounds like a drug company. The stock has a 3 Long Term PowerRating. They just reported great 3rd quarter results with 26% diluted EPS and an 18% increase in sales. Very positive words from the CEO Martin Loeffler about future prospects, however the stock has been downtrending on the chart.
Genzyme (NasdaqGS:GENZ - News) - This biotech company has earned a 5 rating and is the second highest ranked stock in the Nasdaq index. They reported very positive 3rd quarter results with revenue climbing 21% and just received a $100 million licensing fee for a genetic disease drug still in late stage testing. Technically, price has formed a rough channel between $65.00 and $70.00/share. The 50-day simple moving average is approaching the top of this channel at 71.53. Some Technical Analysts would say its setting up for a break out near the upper channel level.
Johnson & Johnson (NYSE:JNJ - News) - This drug giant is the number one rated stock in the DJIA Long Term PowerRatings. They just reported 3rd quarter results with sales up 6.4% and EPS increasing by 10.4%. Technically, price has bounced off of the $54.00/share range and appears to be headed toward the 50-day simple moving average presently at $62.30/share.
Stocks In The News
Here are a handful of stocks that caught my eye from the news wires this week:
Citigroup NYSE:C - Exploded up on the heals of an aggressive government plan to save the ailing bank. $306 billion of guarantees provided investors confidence to jump back into C and other financial shares gained as a result.
New York Times (NYSE:NYT - News) - Citigroup raised its rating to hold from sell resulting in shares surging.
E*Trade (NasdaqGS:ETFC - News) - Rocketed after the discount stock broker stated it feels confident that it will be able to access the government TARP program.
Google (NasdaqGS:GOOG - News) - Barclay's statement that selling was overdone in the search engine company triggered buying in the search engine company.
This Week's Top Performers
Owens Corning (NYSE:OC - News)
Nuance Communication (NasdaqGS:NUAN - News)
InterDigital Communications (NasdaqGS:IDCC - News)
This Week's Worst Performers
KV Pharma. (NYSE:KV-A - News)
Arbitron (NYSE:ARB - News)
Ultra Short Basic Materials (NYSE:SMN - News)
What To Watch For Next Week
Monday - ISM Index
Tuesday - Auto Sales
Wednesday - Productivity
Thursday - Initial Claims, Factory Orders
Friday - Non Farm Payrolls, Consumer Credit